Detecting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions Using T2w-Derived Radiomics Feature Maps in 3T Prostate MRI

Detecting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions Using T2w-Derived Radiomics Feature Maps in 3T Prostate MRI

Prostate Imaging Reporting and Data System version 2.1 (PI-RADS) category 3 lesions are a challenge in the clinical workflow. A better detection of the infrequently occurring clinically significant prostate cancer (csPCa) in PI-RADS 3 lesions is an important objective. The purpose of this study was...

Full description

Saved in:

Bibliographic Details
Main Authors:	Laura J. Jensen, Damon Kim, Thomas Elgeti, Ingo G. Steffen, Lars-Arne Schaafs, Matthias Haas, Lukas J. Kurz, Bernd Hamm, Sebastian N. Nagel
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Current Oncology
Subjects:	prostate magnetic resonance imaging radiomics prostatic neoplasms prostatitis
Online Access:	https://www.mdpi.com/1718-7729/31/11/503
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Repeatability, reproducibility, and the effects of radiotherapy on radiomic features of lowfield MR-LINAC images of the prostate
by: Parker Anderson, et al.
Published: (2025-01-01)

An MRI radiomics model for predicting a prostate-specific antigen response following abiraterone treatment in patients with metastatic castration-resistant prostate cancer
by: Yi Wu, et al.
Published: (2025-01-01)

Development of novel nomograms for predicting prostate cancer in biopsy-naive patients with PSA < 10 ng/ml and PI-RADS ≤ 3 lesions
by: Jia-gui Chai, et al.
Published: (2025-01-01)

Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions
by: Yongming Jin, et al.
Published: (2025-01-01)

Artificial intelligence and radiomics applied to prostate cancer bone metastasis imaging: A review
by: S. J. Pawan, et al.
Published: (2024-12-01)

Optimizing radiomics for prostate cancer diagnosis: feature selection strategies, machine learning classifiers, and MRI sequences
by: Eugenia Mylona, et al.
Published: (2024-11-01)

Developmental trends and knowledge frameworks in the application of radiomics in prostate cancer: a bibliometric analysis from 2000 to 2024
by: Pan Hao, et al.
Published: (2024-12-01)

Personalized optimization of systematic prostate biopsy core number based on mpMRI radiomics features: a large-sample retrospective analysis
by: Zhenlin Chen, et al.
Published: (2025-01-01)

Interpretable machine learning model for predicting clinically significant prostate cancer: integrating intratumoral and peritumoral radiomics with clinical and metabolic features
by: Wenjun Zhao, et al.
Published: (2024-12-01)

Biparametric MRI-based radiomics for noninvastive discrimination of benign prostatic hyperplasia nodules (BPH) and prostate cancer nodules: a bio-centric retrospective cohort study
by: Yangbai Lu, et al.
Published: (2025-01-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men
by: Abudu EK, et al.
Published: (2025-01-01)

Severe Xanthogranulomatous prostatitis mimicking prostate cancer: a case report
by: Wael Abdo Hassan, et al.
Published: (2024-12-01)

The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)

Prostatitis, benign prostatic hyperplasia, and prostate cancer: a bidirectional Mendelian randomization study and clinical implications for these patients’ populations
by: Yi Wang, et al.
Published: (2024-12-01)

Effect of Antibiotic on Men with Raised Prostatic-Specific Antigen (4-10 ng/ml)
by: Abdulsattar J. Ali, et al.
Published: (2020-12-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Giant sarcoma of the prostate stroma: Clinical, radiological and histopathological analysis of a rare prostatic cancer
by: Alan de Jesus Martinez Salas, et al.
Published: (2024-11-01)

Development and Validation of an MRI‐Based Radiomics Nomogram to Predict the Prognosis of De Novo Oligometastatic Prostate Cancer Patients
by: Wen‐Qi Liu, et al.
Published: (2024-12-01)

The factors impacting on Gleason score upgrading in prostate cancer with initial low Gleason scores
by: Tzu-Heng Huang, et al.
Published: (2025-02-01)

Optimizing Multiparametric MRI Protocols for Prostate Cancer Detection: A Comprehensive Assessment Aligned with PI‐RADS Guidelines
by: Mohammad Hossein Jamshidi, et al.
Published: (2024-11-01)

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

COMPARATIVE EVALUATION OF CURRENT METHODS OF ANESTHESIA IN PERFORMANCE OF TRANSRECTAL PROSTATE BIOPSY
by: M. E. Topuzov, et al.
Published: (2015-10-01)

A case of stromal sarcoma of the prostate with the incidental detection of prostate adenocarcinoma
by: Shang Xu, et al.
Published: (2025-03-01)

Bidirectional influence between benign prostatic hyperplasia, prostate cancer, and prostatitis and mental disorders: two-sample and multivariate mendelian randomization analyses
by: Xiangyu Chen, et al.
Published: (2024-12-01)

Prostate Specific Antigen Level and Gleason Score in Indonesian Prostate Cancer Patients
by: Muhammad Imam Al Kautsar Herawan, et al.
Published: (2024-09-01)

Magnetic resonance imaging‐based radiomics nomogram for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high‐risk non‐metastatic prostate cancer
by: Xiao‐Hui Wu, et al.
Published: (2024-07-01)

Experience in the use of MRI-ultrasound fusion-targeted biopsy of the prostate for the diagnosis of prostate cancer
by: E. S. Nevirovich, et al.
Published: (2018-10-01)

Evaluation of Prostate Imaging Reporting and the PI-RADS Version 2 Data System for Prostate Cancer Detection: a Retrospective Single-Center Study
by: Lora Grbanović, et al.
Published: (2024-01-01)

Prostatic Artery Embolization: A Systematic Review Article
by: Pooja Atkuri, et al.
Published: (2025-01-01)

Primary Prostatic Stromal Sarcoma: A Case Report and Review of the Literature
by: Enes Erul, et al.
Published: (2024-11-01)

Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
by: Dae Yul Yang, et al.
Published: (2025-01-01)

A Rare Metastasis of Prostate Cancer
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01)

Prostate Cancer Screening: Is it Recommended in 2024?
by: Dr. Ali Thwaini
Published: (2024-12-01)

Association between calcium intake and prostate neoplasm; a systematic review and meta-analysis
by: Shahin Asgari Savadjani, et al.
Published: (2024-03-01)

3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study
by: Jie Bao, et al.
Published: (2025-01-01)

Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01)

Systematic and Targeted Prostate Biopsy: a Five-Year Experience in a High-Volume Center
by: Toni Zekulić, et al.
Published: (2024-01-01)

Radiomics based Machine Learning Models for Classification of Prostate Cancer Grade Groups from Multi Parametric MRI Images
by: Fatemeh Zandie, et al.
Published: (2024-12-01)

A review of whole gland prostate brachytherapy with focal dose escalation to intra-prostatic lesions: Clinical efficacy and technical aspects
by: Joel Poder, et al.
Published: (2024-10-01)